Clinical data | |
---|---|
Trade names | Frova, Migard, others |
Other names | Frovatriptan succinate, 6-methylamino-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide (6R)-6-methylamino-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide |
AHFS/Drugs.com | Monograph |
MedlinePlus | a604013 |
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Triptan[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 20–30% |
Metabolism | Liver |
Elimination half-life | 26 hours |
Excretion | Kidney |
Identifiers | |
| |
Chemical and physical data | |
Formula | C14H17N3O |
Molar mass | 243.310 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Frovatriptan, sold under the brand name Frova among others, is a medication used to treat migraine headaches.[1] It may also be used to prevent menstrual migraine.[2] It is taken by mouth.[2]
Common side effects include tiredness, numberness, flushing, dry mouth, pain, heart burn, and trouble sleeping.[1] Other side effects may include serotonin syndrome, high blood pressure, heart attack, and medication overuse headaches.[1] Safety in pregnancy is unclear, and use within 24 hours of breastfeeding is not recommended.[3] It is a triptan.[1]
was approved for medical use in the United States in 2001.[1] It is available as a generic medication. In the United Kingdom 6 pills of 2.5 mg costs the NHS about £6 as of 2021.[2] This amount in the United States costs about 67 USD.[4]
References edit
- ^ a b c d e f g h "Frovatriptan Monograph for Professionals". Drugs.com. Archived from the original on 26 January 2021. Retrieved 12 December 2021.
- ^ a b c d BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 500. ISBN 978-0857114105.
- ^ "Frovatriptan (Frova) Use During Pregnancy". Drugs.com. Archived from the original on 28 November 2020. Retrieved 12 December 2021.
- ^ "Frovatriptan Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 11 October 2016. Retrieved 12 December 2021.